On CNBC's “Mad Money Lightning Round,” Jim Cramer said Recursion Pharmaceuticals, Inc. RXRX is a “terrific spec” and he recommended buying the same.
On May 9, Recursion Pharmaceuticals reported better-than-expected first-quarter financial results.
Corning Incorporated GLW has “not been able to generate the kind of return that I've wanted,” Cramer said. “I would not be a buyer all the way up here.”
See Also: Jim Cramer Says This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir
On May 7, Mizuho analyst John Roberts initiated coverage on Corning with a Neutral rating and announced a price target of $36.
When asked about Intuitive Machines, Inc. LUNR, Cramer said, “I'm not there on that.”
On May 14, Intuitive Machines reported a first-quarter GAAP loss of $2.70 per share.
The “Mad Money” host said he would hold off Axon Enterprise, Inc. AXON right now.
On May 6, Axon Enterprise posted better-than-expected results for its first quarter, reporting adjusted earnings of $1.15 per share beating market estimates of 94 cents per share.
“I like defense contractors,” Cramer said when asked about Kratos Defense & Security Solutions, Inc. KTOS. “I think you stay on it, maybe even buy more.”
On May 7, Kratos Defense & Security posted stronger-than-expected results for its first quarter.
Merit Medical Systems, Inc. MMSI is “good,” Cramer said.
On April 30, Merit Medical Systems posted upbeat results for the first quarter.
Price Action:
- Corning shares gained 0.3% to settle at $36.58 on Wednesday.
- Axon shares fell 1.1% to close at $284.87 on Wednesday.
- Recursion Pharmaceuticals shares slipped 1.6% to settle at $9.36.
- Intuitive Machines shares fell 1.2% to settle at $5.06 on Wednesday.
- Kratos Defense shares fell 1.3% to settle at $21.41.
- Merit Medical shares fell 0.2% to close at $82.14 on Wednesday.
Read Next: Top 5 Industrials Stocks That May Explode This Quarter
Image: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.